GSE252944 AKT inhibition 11 v 14 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE252944_AKT inhibition_11_v_14_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE252944_AKT inhibition_11_v_14_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE252944_AKT inhibition_11_v_14_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE252944_AKT inhibition_11_v_14_human_up.

Results found

Linked to

 

Label

Description

 

Gene

MSL complex subunit 3B

Gene

CASTOR family member 3, pseudogene

Gene

long intergenic non-protein coding RNA 662

Gene

NBPF member 26

Gene

long intergenic non-protein coding RNA 3040

Gene

high mobility group box 1 pseudogene 5

Gene

urothelial cancer associated 1

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

CTA-216E10.6

Gene

endogenous Bornavirus like nucleoprotein 3, pseudogene

  • Gene

    MSL complex subunit 3B


  • Gene

    CASTOR family member 3, pseudogene


  • Gene

    long intergenic non-protein coding RNA 662



  • Gene

    long intergenic non-protein coding RNA 3040


  • Gene

    high mobility group box 1 pseudogene 5


  • Gene

    urothelial cancer associated 1


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene



  • Gene

    endogenous Bornavirus like nucleoprotein 3, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.